Supporting a healthier planet while delivering medicines to millions
Providing access to medicines depends on resilient, efficient and responsible operations. We recognise that responsibly managing energy, water and natural resources is essential to sustaining our operations and supporting the millions of patients who rely on our medicines every year. In 2025, our medicines helped treat 222 million patients globally, reinforcing the importance of building a business that can deliver long-term value while reducing its environmental impact. Our approach focuses on the areas where we can have the greatest impact: reducing greenhouse gas emissions, improving energy efficiency and strengthening water stewardship, particularly in regions where water scarcity represents a growing challenge.
Figures as of 2025
Advancing our climate ambitions
19%
of our electricity came from renewable sources
354% vs 2021
Increase in our onsite renewable energy generation capacity
100%
Of the electricity used in our European facilities are from renewable sources
1MW solar installation
Completed in Jordan ahead of schedule
Since 2020, we have reduced our Scope 1 and Scope 2 greenhouse gas emissions by 18%, demonstrating continued progress towards our target of a 25% reduction by 2030.
This progress has been supported by investments in energy efficiency and renewable energy across our manufacturing network.
Managing water where it matters most
Many of the countries where Hikma operates face significant water stress, especially across the Middle East and North Africa. In 2025 we strengthened our approach by:
By 2028, we aim to implement key elements of the ISO 46001 Water Efficiency Management System across our MENA operations, helping embed best practice water management throughout the region.
Emissions data
2025
Hikma GHG Emissions FY25 – Verification Statement
2024
Hikma GHG Emissions - EcoAct - 2024 - FY
Sievo Scope 3 Limited Assurance Statement Validity Confirmation
Hikma scope 3 emissions Validity statement conducted by EY through Sievo
Scope 3 CO2 analytics methodology description
2022 and 2023
Hikma GHG Emissions - EcoAct - 2023 - FY
Hikma scope 3 emissions assurance statement for 2023 conducted by EY through Sievo